Ausdal Financial Partners’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,575
Closed -$36.6K 585
2024
Q3
$36.6K Hold
24,575
﹤0.01% 511
2024
Q2
$30.7K Hold
24,575
﹤0.01% 490
2024
Q1
$29.5K Hold
24,575
﹤0.01% 463
2023
Q4
$37.1K Hold
24,575
﹤0.01% 451
2023
Q3
$39.3K Sell
24,575
-600
-2% -$1.09K 0.01% 426
2023
Q2
$54.6K Hold
25,175
0.01% 421
2023
Q1
$36.8K Hold
25,175
0.01% 439
2022
Q4
$31.5K Buy
25,175
+1,000
+4% +$1.58K ﹤0.01% 442
2022
Q3
$46K Hold
24,175
0.01% 434
2022
Q2
$61K Hold
24,175
0.01% 437
2022
Q1
$83K Buy
24,175
+2,000
+9% +$7.06K 0.01% 467
2021
Q4
$107K Hold
22,175
0.01% 469
2021
Q3
$81K Hold
22,175
0.01% 460
2021
Q2
$90K Hold
22,175
0.01% 451
2021
Q1
$95K Sell
22,175
-1,825
-8% -$8.72K 0.02% 433
2020
Q4
$83K Buy
24,000
+5,000
+26% +$20.9K 0.02% 407
2020
Q3
$51K Buy
19,000
+9,000
+90% +$38K 0.01% 349
2020
Q2
$34K Buy
+10,000
New +$22.4K 0.01% 289

Other funds holding OPK

Ausdal Financial Partners's OPK Position: Q4 2024 in Review

Ausdal Financial Partners sold out of Opko Health (OPK) in Q4 2024, closing a stake of 24,575 shares — an estimated $36.6K sold.

Ausdal Financial Partners first reported a position in OPK in Q2 2020 and held it in 18 quarters. The position peaked at $107K in Q4 2021. 235 funds tracked by Wall St. Rank hold OPK as of Q4 2024.

  • Ausdal Financial Partners reported no remaining Opko Health position as of Q4 2024 after selling out during the quarter.
  • Ausdal Financial Partners sold 24,575 Opko Health shares in Q4 2024, an estimated $36.6K.
  • Ausdal Financial Partners first reported a position in Opko Health in Q2 2020 and held it in 18 quarters.
  • Ausdal Financial Partners's Opko Health position peaked at $107K in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q4 2024.

Based on Ausdal Financial Partners's 13F filing for Q4 2024, filed 12 Feb 2025.